Showing results (131-140 of 144) with videos related to
Sort By:
Pageof 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primatesWen Qing Yang, Xueqing Lun, Cheryl Ann Palmer, et al.European Journal of Cancer (Oxford, England : 1990)|September 1, 2023
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastasesAmmoren E Dohm, Justyn Y Nakashima, Hruday Kalagotla, et al.Breast Cancer Research and Treatment|October 20, 2021
The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIsMatthew N Mills, Thrisha K Potluri, Yuki Kawahara, et al.Neuro-Oncology|January 24, 2025
Phase II Trial of Brain MRI Surveillance in Stage IV Breast CancerKamran A Ahmed, Youngchul Kim, Avan J Armaghani, et al.Neuro-Oncology Advances|March 26, 2025
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomasSolmaz Sahebjam, Raju R Raval, Peter A Forsyth, et al.Neuro-Oncology|May 27, 2026
Breaking Barriers in Leptomeningeal Disease: A SNO-ASCO Consensus Review on Clinical Trial Design and Basic Science IntegrationYolanda Piña, Maxine Umeh Garcia, Adrienne Boire, et al.The New England Journal of Medicine|August 23, 2018
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the BrainHussein A Tawbi, Peter A Forsyth, Alain Algazi, et al.Biorxiv : the Preprint Server for Biology|January 8, 2024
Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal diseaseMariam Lotfy Khaled, Yuan Ren, Ronak Kundalia, et al.Journal for Immunotherapy of Cancer|April 28, 2025
Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib studyKamran A Ahmed, Younchul Kim, Sungjune Kim, et al.Neuro-Oncology|November 11, 2020
Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I studySolmaz Sahebjam, Peter A Forsyth, Nam D Tran, et al.Pageof 15